Sains Malaysiana 43(2)(2014): 233–240

Ko-pengekspresan Reseptor Estrogen beta (ERβ) dan Aktin Otot Licin  pada Tumor Filodes di Payudara: Suatu Kajian Tisu Mikroarai

(The Co-expression of Estrogen Receptor beta (ERβ) and Smooth Muscle Actin in Phyllodes

Tumour of Breast: A Tissue Microarray Study)

NURHAYATI H. MUNAWER¹, SITI-AISHAH MD ALI*¹, REENA MD ZIN¹

& ROHAIZAK MUHAMMAD²

¹Jabatan Potologi, Pusat Perubatan Universiti Kebangsaan Malaysia (PPUKM)

56000 Kuala Lumpur, Malaysia

²Jabatan Surgeri, Pusat Perubatan Universiti Kebangsaan Malaysia (PPUKM)

56000 Kuala Lumpur, Malaysia

Received: 6 December 2012/Accepted: 18 May 2013

ABSTRAK

Proliferasi tumor filodes tertumpu terutama pada bahagian stroma yang dianggap sebagai komponen neoplastik bagi tumor filodes. Reseptor Estrogen (ER) yang memainkan peranan dalam payudara neoplastik juga terlibat dalam perkembangan tumor filodes. ERβ adalah satu jenis klon ER yang dilaporkan hadir pada stroma tumor payudara manakala pengekspresan aktin otot licin (SMA) di stroma dapat membandingkan gred histologi tumor filodes. Kami membandingkan pengekspresan ERβ dengan SMA pada komponen stroma tumor filodes menggunakan teknik tisu mikroarai (TMA). TMA dibentuk ke atas 77 kes tumor filodes (46 benigna, 17 pinggiran dan 14 malignan) menggunakan jarum berdiameter 0.6 mm (Alphelys Plaisir, Perancis) dan pewarnaan imunohistokimia dijalankan menggunakan penanda molekul ERβ dan SMA. Tumor filodes kerap hadir pada wanita berusia lebih daripada 40 tahun dengan tumor filodes benigna menunjukkan median umur pesakit paling rendah (p=0.017). Ekspresi ERβ dalam komponen stroma meningkat dengan gred histologi tumor. Sementara SMA menunjukkan ekspresi pada 62.8, 41.2 dan 57.1%, masing-masing bagi tumor filodes benigna, pinggiran dan malignan. Kedua-dua ERβ (p=0.024) dan SMA lebih cenderung hadir pada wanita ≥40 tahun. Kajian menunjukkan hubungan signifikan antara ko-pengekspresan ERβ dan SMA (p=0.047) dan 65.5% daripadanya adalah wanita berumur lebih daripada 40 tahun. Ekspresi SMA yang tinggi pada stroma tumor filodes benigna mungkin menunjukkan potensi proliferasi tumor ini untuk menjadi malignan. Ekspresi tinggi ERβ dengan tumor filodes malignan dan hubungannya dengan SMA mencadangkan ko-pengekspresan kedua-dua penanda molekul ini mungkin berperanan dalam tumorigenesis stroma tumor filodes.

Kata kunci: ERβ; SMA; tisu mikroarai; tumor filodes

ABSTRACT

Proliferation of phyllodes tumour is mainly in the stromal that is considered as the neoplastic component of phyllodes tumour. Estrogen Receptor (ER) that plays an important role in breast neoplasm is also involved in progression of phyllodes tumour. ERβ is a type of ER which was reported to be expressed in the breast stroma while the expression of smooth muscle actin (SMA) in the stroma may differentiate histological grade of phyllodes tumour. We compared the expression of ERβ to SMA in stromal component of phyllodes tumour using tissue microarray (TMA) technique. A TMA was constructed on 77 cases of phyllodes tumour (46 benign, 17 boderline and 14 malignant) using 0.6 mm punch kit (Alphelys Plaisir, France) and immunohistochemical staining was done using ERβ and SMA. Phyllodes tumour seen in women aged more than 40 year-old with benign phyllodes tumour showed the lowest median of age (p=0.017). ERβ expression in stromal component increased with histological grade of the tumour. SMA was positive in 62.8, 41.2 and 57.1% of benign, borderline and malignant phyllodes tumour, respectively. Both ERβ (p=0.024) and SMA were commonly expressed in women aged ≥40 years. We found a significant co-expression of ERβ and SMA (p=0.047) and 65.5% of these cases occured in women aged more than 40 years-old. The high expression of SMA in stroma of benign phyllodes tumour may demonstrate the potential of proliferation of this tumour to become malignant. High expression of ERβ of malignant phyllodes tumour and its significant association with SMA suggests that co-expression of these two markers may play a role in stromal tumorigenesis of phyllodes tumour.

Keywords: ERβ; phyllodes tumour; SMA; tissue microarray

REFERENCES

Ang, M.K., Ooi, A.S., Thike, A.A., Tan, P., Zhang, Z., Dykema, K., Furge, K., Teh, B.T. & Tan, P.H. 2011. Molecular classification of breast phyllodes tumors: Validation of the histologic grading scheme and insights into malignant progression. Breast Cancer Research Treatment 129: 319- 329.

Bubendorf, L., Nocito, A., Moch, H. & Sauter, G. 2001. Tissue microarray (TMA) technology: Miniaturized pathology archives for high-throughput in situ studies. Journal of Pathology 195: 72-79.

Chen, C.M., Chen, C.J., Chang, C.L., Shyu, J.S., Hsieh, H.F. & Harn, H.J. 2000. CD34, CD117, and actin expression in phyllodes tumor of the breast. Journal of Surgical Research 94: 84-91.

Chong, J.K. & Woo, H.K. 1993. Patterns of p53 expression in phyllodes tumors of the breast. Journal of Korean Medical Science 8(5): 325-328.

Chua, C.L., Thomas, A. & Ng, B.K. 1989. Cystosarcoma phyllodes: A review of surgical options. Surgery 105: 141- 147.

Cîmpean, A.M., Raica, M. & Narita, D. 2005. Diagnostic significance of the immunoexpression of CD34 and smooth muscle cell actin in benign and malignant tumors of the breast. Romanian Journal of Morphology and Embryology 46(2): 123-129.

Clark, S.E., Warwick, J., Carpenter, R., Bowen, R.L., Duffy, S.W. & Jones, J.L. 2011. Molecular subtyping of DCIS: Heterogeneity of breast cancer reflected in pre-invasive disease. British Journal of Cancer 104: 120-127.

Feakins, R.M., Mulcahy, H.E., Nickols, C.D. & Wells, C.A. 1999. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome. Histopathology 35: 162-169.

Feakins, R.M., Wells, C.A., Young, K.A. & Sheaff, M.T. 2000. Platelet-derived growth factor expression in phyllodes tumors and fibroadenomas of the breast. Human Pathology 31(10): 1214-1222.

Esposito, N.N., Mohan, D., Brufsky, A., Lin, Y., Kapali, M. & Dabbs, D.J. 2006. Phyllodes tumor. A clinicopathologic and immunohistochemical study of 30 cases. Archives Pathology & Laboratory Medicine 130: 1516–1521.

Glass, A.G., Lacey Jr., J.V., Carreon, J.D. & Hoover, R.N. 2007. Breast cancer incidence, 1980-2006: Combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. Journal of the National Cancer Institute 99: 1152-1161.

Gustafsson, J.A. 1999. Estrogen receptor β- a new dimension in estrogen mechanism of action. Journal of Endocrinology 163: 379-383.

Iau, P.T., Lim, T.C., Png, D.J. & Tan, W.T. 1998. Phyllodes tumour: An update of 40 cases. ANNALS Academy of Medicine Singapore 27(2): 200-203.

Jacobs, T.W., Chen, Y.Y., Guinee, D.G.Jr., Holden, J.A., Cha, I., Bauermeister, D.E., Hashimoto, B., Wolverton, D. & Hartzog, G. 2005. Fibroepithelial lesions with cellular stroma on breast core needle biopsy: Are there predictors of outcome on surgical excision? American Journal of Clinical Pathology 3: 342-354.

Jara-Lazaro, A.R. & Tan, P.H. 2009. Molecular pathogenesis of progression and recurrence in breast phyllodes tumors. American Journal of Translational Research 1(1): 23-34.

Kilarski, W.W., Jura, N. & Gerwins, P. 2005. An ex vivo model for functional studies of myofibroblasts. Laboratory Investigation 85(5): 643-654.

Kuijper, A., Buerger, H., Simon, R., Schaeter, K.L., Croonen, A., Boecker, W., van der Wall, E. & van Diest, P.J. 2002. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. Journal of Pathology 197(5): 575-581.

Liporace, J., Willcox, K. & Thomas, D.A. 2008. Neurologic considerations in the postmenopausal women. Dlm Clinical Neurology of the Older Adult. Edisi ke-2, disunting oleh Siven, J.I. & Malamut, B.L. Philadelphia: Lippincott Williams & Wilkins. hlm. 54-64.

Munirah, M.A., Siti-Aishah, M.A., Reena, M.Z., Sharifah, N.A., Rohaizak, M., Norlia, A., Rafie, M.K.M., Asimiati, A., Hisham, A., Fuad, I., Shahrun, N.S. & Das, S. 2011. Identification of different subtypes of breast cancer using tissue microarray. Romanian Journal of Morphology and Embryology 52(2): 669-677.

Nakopoulou, L., Lazaris, A.C., Panayotopoulou, E.G., Giannopoulou, I., Givalos, N., Markaki, S. & Keramopoulos, A. 2004. The favourable prognostic value of oestrogen receptor β immunohistochemical expression in breast cancer. Journal of Clinical Pathology 57: 523-528.

Noranizah, W., Siti-Aishah, M.A., Munirah, M.A., Norazlin, M.H., Rohaizak, M., Naqiyah, I., Sharifah, N.A. & Das, S. 2010. Immunohistochemical expression of vascular endothelial growth factor (VEGF) and p53 in breast lesions. Clinica Terapeutica 161(2): 129-137.

Patrone, C., Cassel, T.N., Pettersson, K., Piao, Y.S., Cheng, G., Ciana, P., Maggi, A., Warner, M., Gustafsson, J.A. & Nord, M. 2003. Regulation of postnatal lung development and homeostasis by estrogen receptor beta. Molecular of Cell Biology 23(23): 8542-8552.

Nurhayati, H.M., Reena, M.Z., Siti-Aishah, M.A., Rohaizak, M., Jasmi, A.K., Srijit, D. 2012. ER. P53 and MIB-1 are significantly associated with malignant phyllodee tumor. Biomedical Journal 35(6): 486-492.

Rousseau, M.E. 2004. Health care of midlife and aging women. Dlm Varney’s Midwifery. Edisi ke-4, disunting oleh Varney, H., Kriebs, J.M. & Gegor, C.L. Sudbury: Jones and Bartlett Publishers.

Sapino, A., Bosco, M., Cassoni, P., Castellano, I., Arisio, R., Cserni, G., Dei Tos, A.P., Fortunati, N., Catalano, M.G. & Bussolati, G. 2006. Estrogen receptor-β is expressed in stromal cells of fibroadenoma and phyllodes tumors of the breast. Modern Pathology 19: 599-606.

Scobie, G.A., Macpherson, S., Millar, M.R., Groome, N.P., Romana, P.G. & Saunders, P.T.K. 2002. Human oestrogen receptor: Differential expression of Eralpha and beta and the identification of Erbeta variants. Steroids 67: 985-992.

Shaaban, A., O’Neill, P.A., Davies, M.P.A., Sibson, R., West, C.R., Paul, H. & Christopher, S. 2003. Declining estrogen receptor-[beta] expression defines malignant progression of human breast neoplasia. The American Journal of Surgical Pathology 12(27): 1502-1512.

Shantakumar, S., Terry, M.B., Teitelbaum, S.L., Britton, J.A., Millikan, R.C., Moorman, P.G., Neugut, A.I. & Gammon, M.D. 2007. Reproductive factors and breast cancer risk among older women. Breast Cancer Research and Treatment 102: 365-374.

Sotheran, W., Domjan, J., Jeffrey, M., Wise, M.H. & Perry, P.M. 2005. Phyllodes tumours of the breast- a retrospective study from 1982-2000 of 50 cases in Portsmouth. Annals of Royal College of Surgeons of England 87: 339-344.

Speirs, V., Skliris, G.P., Burdall, S.E. & Carder, P.J. 2002. Distinct expression patterns of ERα and ERβ in normal human mammary gland. Journal of Clinical Pathology 55: 371-374.

Tan, P.H., Jayabaskar, T., Chuah, K.L., Lee, H.Y., Tan, Y., Hilmy, M., Hung, H., Selvarajan, S. & Bay, B.H. 2005. Phyllodes tumors of the breast. The role of pathologic parameters. American Journal of Clinical Pathology 123: 529-540.

Tan, P.H., Tse, G., Lee, A., Simpson, J.F. & Hanby, A.M. 2012a. Fibroepithelial tumors. Dlm. World Health Organization Classification of Tumours. Pathology WHO Classification of Tumours of the Breast disunting oleh Lakhani, S.R., Ellis, I.O., Schnitt, S.J., Tan, P.H. & van de Vijver, M.J. Lyon: IARC Press.

Tan, P.H., Thike, A.A., Tan, W.J., Myint Thu, M.M., Busmanis, I., Li, H., Chay, W.Y., Tan, M.H. & The Phyllodes Tumour Network Singapore. 2012b. Predicting clinical behaviour of breast phyllodes tumours: A nomogram based on histological criteria and surgical margins. Journal of Clinical Pathology 65(1): 69-76.

Tsai, W.C., Jin, J.S., Yu, J.C. & Sheu, L.F. 2006. CD10, Actin, and Vimentin expression in breast phyllodes tumors correlates with tumor grade of WHO grading. International Journal of Surgical Pathology 14: 127-131.

Tse, M.K., Lee, C.S., Kung, Y.L., Scolyer, F., Law, R.A., Bonita, K.B., Lau, T.S. & Putti, T.C. 2002. Hormonal receptors expression in epithelial cells of mammary phyllodes tumors correlates with pathologic grade of the tumor. A multicenter study of 143 cases. American Journal of Clinical Pathology 118: 522-526.

Tse, M.K., Chai, B., Lau, K.M., Scolyer, R., Lee, C.S., Karim, R.Z., Putti, T.C., Law, B.K., Lui, P.C. & Tan, P.H. 2007. Endothelin-1 expression correlates with a typical histological features in mammary phyllodes tumours. Journal of Clinical Pathology 60(9): 1051-1056.

Wittliff, J.L., Pasic, R. & Bland, K.I. 1998. Steroid and peptide hormone receptors: Methods, quality control and clinical use. Dlm The Breast: Comprehensive Management of Benign and Malignant Diseases. Edisi pertama, disunting oleh Bland, K.I. & Copeland, E.M. Philadephia: Elsevier Saunder Publisher.

Yonemori, K., Hasegawa, T., Shimizu, C., Shibata, T., Matsumoto, K., Kauno, T., Ando, M., Katsumata, N. & Fujiwara, Y. 2006. Correlation of p53 and MIB-1 expression with both the systemic recurrence and survival in cases of phyllodes tumors of the breast. Pathology, Research & Practice 202: 705-712.

Zainal, A.O. & Nor-Saleha, I.T. 2011. Malaysia Cancer Statistics- Data and Figure. National Cancer Registry Report. Kuala Lumpur: Ministry of Health Malaysia.

*Corresponding author; email: saishah@ppukm.ukm.edu.my